Literature DB >> 20671379

Bystander killing effect of tymidine kinase gene-transduced adult bone marrow stromal cells with ganciclovir on malignant glioma cells.

Kentaro Mori1, Junko Iwata, Masahiro Miyazaki, Hideo Osada, Yuichi Tange, Takuji Yamamoto, Yasuhisa Aiko, Masaru Tamura, Toshihiko Shiroishi.   

Abstract

Transduction of the suicide gene of Herpes simplex virus thymidine kinase (Hsv-tk) into glioma cells or neural stem cells combined with pro-drug ganciclovir (GCV) treatment has been effective to treat experimental glioma in the rat through the bystander effect. Bone marrow stromal cells (MSCs) in the adult bone marrow have tropism for brain tumors and act as tumor stromal cells. Whether adult MSCs expressing Hsv-tk can also act as effector cells of the bystander killing effect on murine glioma cells was investigated. In vitro study of co-culture between 9L/LacZ (9L) glioma cells and Hsv-tk-transduced MSCs (MSCs/tk(+)) followed by GCV administration in the culture medium resulted in apparent nuclear morphological changes in the 9L glioma cells surrounding the MSCs/tk(+). 9L glioma cell survival in the presence of MSCs/tk(+) and GCV treatment was quantitatively measured and showed significant decrease of 9L glioma cell proliferation with higher MSCs/tk(+) ratio and GCV concentration. Intracerebral co-inoculation experiments in Fisher rats used 9L glioma cells and either MSCs/tk(+) or Hsv-tk-non-transduced MSCs (MSCs/tk(-)) followed by intraperitoneal injection of GCV (100 mg/kg, daily for 7 days). The animals co-inoculated with 9L glioma cells and MSCs/tk(+) showed significant retardation of tumor growth and prolongation of survival time compared with the animals with 9L glioma cells and MSCs/tk(-). Quantitative findings were established of the novel effects of adult MSCs/tk(+) as effector cells of the bystander killing effect on glioma cells.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20671379     DOI: 10.2176/nmc.50.545

Source DB:  PubMed          Journal:  Neurol Med Chir (Tokyo)        ISSN: 0470-8105            Impact factor:   1.742


  11 in total

Review 1.  Engineering antiphagocytic biomimetic drug carriers.

Authors:  Alicia Sawdon; Ching-An Peng
Journal:  Ther Deliv       Date:  2013-07

2.  The adeno-associated virus-mediated HSV-TK/GCV suicide system: a potential strategy for the treatment of bladder carcinoma.

Authors:  Jian Gang Pan; Xing Zhou; Runqi Luo; Rui Fa Han
Journal:  Med Oncol       Date:  2011-10-20       Impact factor: 3.064

3.  Bicistronic vector for combined expression of the HSVtk killer gene and cytokine GM-CSF gene in cancer cells.

Authors:  I V Alekseenko; E P Kopantzev; T V Vinogradova; E D Sverdlov
Journal:  Dokl Biochem Biophys       Date:  2011 Jul-Aug       Impact factor: 0.788

4.  Use of genetically engineered stem cells for glioma therapy.

Authors:  Hiroki Namba; Hiroshi Kawaji; Tomohiro Yamasaki
Journal:  Oncol Lett       Date:  2015-11-04       Impact factor: 2.967

5.  Engineered Mesenchymal Stem Cells as an Anti-Cancer Trojan Horse.

Authors:  Adam Nowakowski; Katarzyna Drela; Justyna Rozycka; Miroslaw Janowski; Barbara Lukomska
Journal:  Stem Cells Dev       Date:  2016-09-07       Impact factor: 3.272

6.  Frontiers in Suicide Gene Therapy of Cancer.

Authors:  Marek Malecki
Journal:  J Genet Syndr Gene Ther       Date:  2012-10-22

7.  A Universal Tumor-Specific Promoter for Cancer Gene Therapy.

Authors:  I V Alekseenko; V V Pleshkan; A V Sass; O B Filyukova; E V Snezhkov; E D Sverdlov
Journal:  Dokl Biochem Biophys       Date:  2018-07-14       Impact factor: 0.788

8.  Strategies in gene therapy for glioblastoma.

Authors:  Aneta Kwiatkowska; Mohan S Nandhu; Prajna Behera; E Antonio Chiocca; Mariano S Viapiano
Journal:  Cancers (Basel)       Date:  2013-10-23       Impact factor: 6.639

9.  Genetically Engineered Multilineage-Differentiating Stress-Enduring Cells as Cellular Vehicles against Malignant Gliomas.

Authors:  Tomohiro Yamasaki; Shohei Wakao; Hiroshi Kawaji; Shinichiro Koizumi; Tetsuro Sameshima; Mari Dezawa; Hiroki Namba
Journal:  Mol Ther Oncolytics       Date:  2017-06-15       Impact factor: 7.200

10.  Assessment of bystander killing-mediated therapy of malignant brain tumors using a multimodal imaging approach.

Authors:  Cindy Leten; Jesse Trekker; Tom Struys; Tom Dresselaers; Rik Gijsbers; Greetje Vande Velde; Ivo Lambrichts; Annemie Van Der Linden; Catherine M Verfaillie; Uwe Himmelreich
Journal:  Stem Cell Res Ther       Date:  2015-09-07       Impact factor: 6.832

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.